Alfonso Quintás-Cardama
Chief Tech/Sci/R&D Officer at FOGHORN THERAPEUTICS INC.
Net worth: - $ as of 2024-03-30
Profile
Alfonso Quintás-Cardama is currently the Chief Medical Officer at Foghorn Therapeutics, Inc. He previously worked as the Head of the Cell & Gene Therapies Unit at GSK Plc, Assistant Professor at The University of Texas M.D.
Anderson Cancer Center, and Chief Medical Officer at TCR2 Therapeutics, Inc. He holds a doctorate degree from the University of Santiago de Compostela.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-01-23 | 0 ( -.--% ) | - $ | 2024-03-30 |
Alfonso Quintás-Cardama active positions
| Companies | Position | Start |
|---|---|---|
| FOGHORN THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 2023-09-10 |
Former positions of Alfonso Quintás-Cardama
| Companies | Position | End |
|---|---|---|
The University of Texas M.D. Anderson Cancer Center
 The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Corporate Officer/Principal | 2013-12-31 |
| GSK PLC | Corporate Officer/Principal | - |
| TCR2 THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | - |
Training of Alfonso Quintás-Cardama
| University of Santiago de Compostela | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| GSK PLC | Health Technology |
| FOGHORN THERAPEUTICS INC. | Health Technology |
| Private companies | 2 |
|---|---|
The University of Texas M.D. Anderson Cancer Center
The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Consumer Services |
TCR2 Therapeutics, Inc.
 TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TCR2 Therapeutics, Inc. is a clinical-stage cell therapy company, which engages in the development of biological drugs and engineering T-cells for cancer therapy. It is also involved in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development. The company was founded by Patrick A. Baeuerle on May 29, 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Alfonso Quintás-Cardama
